Inspire Medical Systems, Inc. (INSP) Research

Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.

Market snapshot

Symbol
INSP
Price
$42.61
Day change
+3.62%
Market cap
$1.2B
P/E ratio
9.33x
52-week range
38.91-147.03
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 1 month
Analyst price target
$57.36

Peer companies

  • Addus HomeCare Corporation (ADUS)
  • Artivion, Inc. (AORT)
  • Ardent Health Partners, LLC (ARDT)
  • Brookdale Senior Living Inc. (BKD)
  • 89bio, Inc. (ETNB)
  • Integer Holdings Corporation (ITGR)
  • LeMaitre Vascular, Inc. (LMAT)
  • Premier, Inc. (PINC)

Recent insider activity

  • Rondoni John — S-Sale (2641 shares) on 2026-05-15
  • Rondoni John — S-Sale (700 shares) on 2026-05-14
  • mcCormick Shawn — S-Sale (696 shares) on 2026-05-08
  • Ellis Gary Lee — A-Award (3562 shares) on 2026-04-30
  • Mead Dana G Jr. — A-Award (3562 shares) on 2026-04-30

Open Inspire Medical Systems, Inc. (INSP) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.